Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 12 | |
Outperform | 17 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 24 analysts offering 12 month price targets for Innovent Biologics Inc have a median target of 59.40, with a high estimate of 77.45 and a low estimate of 32.29. The median estimate represents a 40.92% increase from the last price of 42.15.
High | 83.8% | 77.45 |
Med | 40.9% | 59.40 |
Low | -23.4% | 32.29 |
Earnings history & estimates in CNY
Average growth rate | -1.65% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +80.24% |
More ▼